US Stocks-S&P, Dow futures steady as MidEast deal in focus; chip, software stocks tumble
SPY•Moderna rises after FDA approval
Among other stocks, Moderna MRNA.O rose 3.9% after the U.S. Food and Drug Administration approved the company's flu vaccine for people aged 50 and older.
Energy, Fed policy and data in focus
Brent crude prices LCOc1 traded in a tight range near $80 a barrel as markets were keen on any signs of a deal between Iran and the U.S. A proposed deal between Iran and Oman would give Tehran control over ships entering the Gulf through the Strait of Hormuz, sources told Reuters.
The Federal Reserve has been keen on the outlook for energy costs, with most central bankers voicing that they were prepared to act if price pressures increase. St. Louis Fed President Alberto Musalem is expected to speak on monetary policy later in the day.
